Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 1073618 10.3389/fphar.2022.1073618 Pharmacology Correction Corrigendum: Adenosine receptor stimulation improves glucocorticoid-induced osteoporosis in a rat model Pizzino et al. 10.3389/fphar.2022.1073618 Pizzino Gabriele 1 Irrera Natasha 1 Galfo Federica 1 Oteri Giacomo 2 Atteritano Marco 1 Pallio Giovanni 1 Mannino Federica 1 D’Amore Angelica 1 Pellegrino Enrica 1 Aliquò Federica 1 Anastasi Giuseppe P. 2 Cutroneo Giuseppina 1 Squadrito Francesco 1 Altavilla Domenica 2 Bitto Alessandra 1 * 1 Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy 2 Department of Biomedical Sciences, Dentistry, Morphological and Functional Images, University of Messina, Messina, Italy

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

 *Correspondence: Alessandra Bitto, abitto@unime.it

This article was submitted to Translational Pharmacology, a section of the journal Frontiers in Pharmacology

 02 11 2022 2022 13 1073618 18 10 2022 19 10 2022 Copyright © 2022 Pizzino, Irrera, Galfo, Oteri, Atteritano, Pallio, Mannino, D’Amore, Pellegrino, Aliquò, Anastasi, Cutroneo, Squadrito, Altavilla and Bitto. 2022 Pizzino, Irrera, Galfo, Oteri, Atteritano, Pallio, Mannino, D’Amore, Pellegrino, Aliquò, Anastasi, Cutroneo, Squadrito, Altavilla and Bitto

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Adenosine receptor stimulation improves glucocorticoid-induced osteoporosis in a rat model by Pizzino G, Irrera N, Galfo F, Oteri G, Atteritano M, Pallio G, Mannino F, D’Amore A, Pellegrino E, Aliquò F, Anastasi GP, Cutroneo G, Squadrito F, Altavilla D and Bitto A (2017). Front. Pharmacol. 8:558. doi: 10.3389/fphar.2017.00558 PDRN Adenosine glucocorticoids osteoporosis rats

In the published article, the Conflict of Interest statement was incorrectly filed. The correct Conflict of Interest statement appears below.

“Author FS has received research support from Mastelli for work on polydeoxyribonucleotide. Authors FS, AB and DA are co‐inventors on a patent describing therapeutic polydeoxyribonucleotide activity in chronic intestinal disease. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.